Demographics (2)
- AGE - Subject age at enrollment (phv00529981.v1.p1)
- SEX - Biological sex (phv00529975.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for T-cell lymphoma (phv00529979.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00529980.v1.p1)
Other (13)
- ANALYTE_TYPE - Analyte type (phv00529984.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00529983.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00529974.v1.p1)
- DISEASE_STATUS - Hyperprogression status (phv00530068.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type (phv00530069.v1.p1)
- IS_TUMOR - Tumor status (phv00529985.v1.p1)
- SAMPLE_ID - Sample ID (phv00529982.v1.p1)
- SAMPLE_ID - Sample ID (phv00529977.v1.p1)
- SOURCE_SUBJECT_ID - ID of overlapping subject in prior dbGaP study (phv00530067.v1.p1)
- SUBJECT_ID - Subject ID (phv00529973.v1.p1)
- SUBJECT_ID - Subject ID (phv00529978.v1.p1)
- SUBJECT_ID - Subject ID (phv00529976.v1.p1)
- SUBJECT_SOURCE - Subject repository of prior dbGaP study in which subject also participated (phv00530066.v1.p1)